Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

This publication has 27 references indexed in Scilit:

• Testing cognitive function in elderly populations: the PROSPER study
  Journal of Neurology, Neurosurgery & Psychiatry, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
  The American Journal of Cardiology, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
  Diabetes Care, 1997
• Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS)
  The American Journal of Cardiology, 1995
• Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study
  Neurology, 1994
• Should there be a moratorium on the use of cholesterol lowering drugs?
  BMJ, 1992
• Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study.
  BMJ, 1991
• Beta blockade during and after myocardial infarction: An overview of the randomized trials
  Progress in Cardiovascular Diseases, 1985